Sara Perrotta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sara Perrotta has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Carnevale
Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy
9 shared publications - Giuseppe Lembo
Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed , via dell’Elettronica, Pozzilli, IS 86077
6 shared publications - Lorenzo Carnevale
Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy
6 shared publications - Fabio Pallante
Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy
4 shared publications Agnese Migliaccio
Department of Angiocardioneurology and Translational Medicine, Unit of Neuro and Cardiovascular Pathophysiology, IRCCS Neuromed , Via dell'Elettronica, Pozzilli 86077
2 shared publicationsAzzurra Zonfrilli
Department of Molecular Medicine, “Sapienza” University of Rome, Rome, Italy
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
PI3Kγ signaling controls trafficking of CD8+ T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model
Activated immune cells infiltrate the vasculature during the pathophysiology of hypertension by establishing a vascular-immune interface that contributes to blood pressure dysregulation and organ failure. Many observations indicate a key role of CD8+ T cells in hypertension but mechanisms regulating their activation and interplay with the cardiovascular system are still unknown. In murine model, here we show that a specific member of the phosphoinositide-3-kinases (PI3K) family of lipid kinases, PI3Kγ, is a key intracellular signaling of CD8+ T cells activation and RANTES/CCL5 secretion in hypertension: CCL5-CCR5 signaling is crucial for the establishment of the vascular-immune interface in peripheral organs, lastly contributing to CD8+ tissue infiltration, organ dysfunction and blood pressure elevation. Our studies identify PI3Kγ as a booster of effector CD8+ T cell function, even in the absence of external stimuli. Lastly, an enhanced PI3Kγ signaling mediates the bystander activation of CD8+ T cells and proves effective in transferring the hypertensive phenotype between mice.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Open AccessPI3Kγ signaling controls trafficking of CD8+ T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model
Activated immune cells infiltrate the vasculature during the pathophysiology of hypertension by establishing a vascular-immune interface that contributes to blood pressure dysregulation and organ failure. Many observations indicate a key role of CD8+ T cells in hypertension but mechanisms regulating their activation and interplay with the cardiovascular system are still unknown. In murine model, here we show that a specific member of the phosphoinositide-3-kinases (PI3K) family of lipid kinases, PI3Kγ, is a key intracellular signaling of CD8+ T cells activation and RANTES/CCL5 secretion in hypertension: CCL5-CCR5 signaling is crucial for the establishment of the vascular-immune interface in peripheral organs, lastly contributing to CD8+ tissue infiltration, organ dysfunction and blood pressure elevation. Our studies identify PI3Kγ as a booster of effector CD8+ T cell function, even in the absence of external stimuli. Lastly, an enhanced PI3Kγ signaling mediates the bystander activation of CD8+ T cells and proves effective in transferring the hypertensive phenotype between mice.
- 10 April 2025
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 121 (5) , 817-831
Beta 2 adrenergic receptor gene methylation activates innate lymphoid cells to drive hypertension in lymphocyte deficient hosts
Aims: T cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency. Methods and results: We studied two colonies of T/B cell-deficient RAG-1−/− mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1−/− mice to expand natural killer and innate lymphoid cells (NK/ILCs) that produce pro-hypertensive cytokines. This process is regulated by the DNA methylation status of the β2 adrenergic receptor (β2-AdR). Angiotensin II caused blood pressure elevation in T and NK/ILCs-deficient mice only when either T or NK/ILCs cells were adoptively reconstituted. Additional studies showed NK cell expansion in humans that underwent B cell depletion, and this was augmented in those with hypertension. Conclusions: These findings illustrate that the modulation of NK/ILCs activation by adrenergic signalling governs an escape mechanism in lymphocyte-deficient host, enabling the development of hypertension.
- 10 April 2025
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 121 (5) , 817-831
Beta 2 adrenergic receptor gene methylation activates innate lymphoid cells to drive hypertension in lymphocyte deficient hosts
Aims: T cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency. Methods and results: We studied two colonies of T/B cell-deficient RAG-1−/− mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1−/− mice to expand natural killer and innate lymphoid cells (NK/ILCs) that produce pro-hypertensive cytokines. This process is regulated by the DNA methylation status of the β2 adrenergic receptor (β2-AdR). Angiotensin II caused blood pressure elevation in T and NK/ILCs-deficient mice only when either T or NK/ILCs cells were adoptively reconstituted. Additional studies showed NK cell expansion in humans that underwent B cell depletion, and this was augmented in those with hypertension. Conclusions: These findings illustrate that the modulation of NK/ILCs activation by adrenergic signalling governs an escape mechanism in lymphocyte-deficient host, enabling the development of hypertension.
- Open Access
- 19 November 2024
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 120 (17) , 2160-2162
TGF-β signalling: the Dr Jekyll and Mr Hyde of the aortic aneurysms
Sara Perrotta, Daniela Carnevale, Giuseppe Lembo; TGF-β signalling: the Dr. Jekyll and Mr. Hyde of the aortic aneurysms, Cardiovascular Research, , cvae245
- 19 November 2024
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 120 (17) , 2160-2162
Open AccessTGF-β signalling: the Dr Jekyll and Mr Hyde of the aortic aneurysms
Sara Perrotta, Daniela Carnevale, Giuseppe Lembo; TGF-β signalling: the Dr. Jekyll and Mr. Hyde of the aortic aneurysms, Cardiovascular Research, , cvae245
- 1 March 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (3) , 636-647
Advanced Magnetic Resonance Imaging to Define the Microvascular Injury Driven by Neuroinflammation in the Brain of a Mouse Model of Hypertension
BACKGROUND: Hypertension is one of the main risk factors for dementia and cognitive impairment. METHODS: We used the model of transverse aortic constriction to induce chronic pressure overload in mice. We characterized brain injury by advanced translational applications of magnetic resonance imaging. In parallel, we analyzed peripheral target organ damage induced by chronic pressure overload by ultrasonography. Microscopical characterization of brain vasculature was performed as well, together with the analysis of immune and inflammatory markers. RESULTS: We identified a specific structural, microstructural, and functional brain injury. In particular, we highlighted a regional enlargement of the hypothalamus, microstructural damage in the white matter of the fimbria, and a reduction of the cerebral blood flow. A parallel analysis performed by confocal microscopy revealed a correspondent tissue damage evidenced by a reduction of cerebral capillary density, paired with loss of pericyte coverage. We assessed cognitive impairment and cardiac damage induced by hypertension to perform correlation analyses with the brain injury severity. At the mechanistic level, we found that CD8+T cells, producing interferon-γ, infiltrated the brain of hypertensive mice. By neutralizing this proinflammatory cytokine, we obtained a rescue of the phenotype, demonstrating their crucial role in establishing the microvascular damage. CONCLUSIONS: Overall, we have used translational tools to comprehensively characterize brain injury in a mouse model of hypertension induced by chronic pressure overload. We have identified early cerebrovascular damage in hypertensive mice, sustained by CD8+IFN-γ+T lymphocytes, which fuel neuroinflammation to establish the injury of brain capillaries.
- 1 March 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (3) , 636-647
Advanced Magnetic Resonance Imaging to Define the Microvascular Injury Driven by Neuroinflammation in the Brain of a Mouse Model of Hypertension
BACKGROUND: Hypertension is one of the main risk factors for dementia and cognitive impairment. METHODS: We used the model of transverse aortic constriction to induce chronic pressure overload in mice. We characterized brain injury by advanced translational applications of magnetic resonance imaging. In parallel, we analyzed peripheral target organ damage induced by chronic pressure overload by ultrasonography. Microscopical characterization of brain vasculature was performed as well, together with the analysis of immune and inflammatory markers. RESULTS: We identified a specific structural, microstructural, and functional brain injury. In particular, we highlighted a regional enlargement of the hypothalamus, microstructural damage in the white matter of the fimbria, and a reduction of the cerebral blood flow. A parallel analysis performed by confocal microscopy revealed a correspondent tissue damage evidenced by a reduction of cerebral capillary density, paired with loss of pericyte coverage. We assessed cognitive impairment and cardiac damage induced by hypertension to perform correlation analyses with the brain injury severity. At the mechanistic level, we found that CD8+T cells, producing interferon-γ, infiltrated the brain of hypertensive mice. By neutralizing this proinflammatory cytokine, we obtained a rescue of the phenotype, demonstrating their crucial role in establishing the microvascular damage. CONCLUSIONS: Overall, we have used translational tools to comprehensively characterize brain injury in a mouse model of hypertension induced by chronic pressure overload. We have identified early cerebrovascular damage in hypertensive mice, sustained by CD8+IFN-γ+T lymphocytes, which fuel neuroinflammation to establish the injury of brain capillaries.
- 1 January 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (1) , 65-75
Brain-Splenic Immune System Interactions in Hypertension: Cellular and Molecular Mechanisms
Hypertension represents a major worldwide cause of death and disability, and it is becoming increasingly clear that available therapies are not sufficient to reduce the risk of major cardiovascular events. Various mechanisms contribute to blood pressure increase: neurohormonal activation, autonomic nervous system imbalance, and immune activation. Of note, the brain is an important regulator of blood pressure levels; it recognizes the peripheral perturbation and organizes a reflex response by modulating immune system and hormonal release to attempt at restoring the homeostasis. The connection between the brain and peripheral organs is mediated by the autonomic nervous system, which also modulates immune and inflammatory responses. Interestingly, an increased autonomic nervous system activity has been correlated with an altered immune response in cardiovascular diseases. The spleen is the largest immune organ exerting a potent influence on the cardiovascular system during disease and is characterized by a dense noradrenergic innervation. Taken together, these aspects led to hypothesize a key role of neuroimmune mechanisms in the onset and progression of hypertension. This review discusses how the nervous and splenic immune systems interact and how the mechanisms underlying the neuroimmune cross talk influence the disease progression.
- 1 January 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (1) , 65-75
Brain-Splenic Immune System Interactions in Hypertension: Cellular and Molecular Mechanisms
Hypertension represents a major worldwide cause of death and disability, and it is becoming increasingly clear that available therapies are not sufficient to reduce the risk of major cardiovascular events. Various mechanisms contribute to blood pressure increase: neurohormonal activation, autonomic nervous system imbalance, and immune activation. Of note, the brain is an important regulator of blood pressure levels; it recognizes the peripheral perturbation and organizes a reflex response by modulating immune system and hormonal release to attempt at restoring the homeostasis. The connection between the brain and peripheral organs is mediated by the autonomic nervous system, which also modulates immune and inflammatory responses. Interestingly, an increased autonomic nervous system activity has been correlated with an altered immune response in cardiovascular diseases. The spleen is the largest immune organ exerting a potent influence on the cardiovascular system during disease and is characterized by a dense noradrenergic innervation. Taken together, these aspects led to hypothesize a key role of neuroimmune mechanisms in the onset and progression of hypertension. This review discusses how the nervous and splenic immune systems interact and how the mechanisms underlying the neuroimmune cross talk influence the disease progression.
- 5 December 2023
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 2 (12) , 1277-1290
Bone marrow adipocytes fuel emergency hematopoiesis after myocardial infarction
After myocardial infarction (MI), emergency hematopoiesis produces inflammatory myeloid cells that accelerate atherosclerosis and promote heart failure. Because the balance between glycolysis and mitochondrial metabolism regulates hematopoietic stem cell homeostasis, metabolic cues may influence emergency myelopoiesis. Here we show, in humans and female mice, that hematopoietic progenitor cells increase fatty acid metabolism after MI. Blockade of fatty acid oxidation by deleting carnitine palmitoyltransferase (Cpt1a) in hematopoietic cells of Vav1Cre/+Cpt1afl/fl mice limited hematopoietic progenitor proliferation and myeloid cell expansion after MI. We also observed reduced bone marrow adiposity in humans, pigs and mice after MI. Inhibiting lipolysis in adipocytes using AdipoqCreERT2Atglfl/fl mice or local depletion of bone marrow adipocytes in AdipoqCreERT2iDTR mice also curbed emergency hematopoiesis. Furthermore, systemic and regional sympathectomy prevented bone marrow adipocyte shrinkage after MI. These data establish a critical role for fatty acid metabolism in post-MI emergency hematopoiesis.
- 5 December 2023
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 2 (12) , 1277-1290
Bone marrow adipocytes fuel emergency hematopoiesis after myocardial infarction
After myocardial infarction (MI), emergency hematopoiesis produces inflammatory myeloid cells that accelerate atherosclerosis and promote heart failure. Because the balance between glycolysis and mitochondrial metabolism regulates hematopoietic stem cell homeostasis, metabolic cues may influence emergency myelopoiesis. Here we show, in humans and female mice, that hematopoietic progenitor cells increase fatty acid metabolism after MI. Blockade of fatty acid oxidation by deleting carnitine palmitoyltransferase (Cpt1a) in hematopoietic cells of Vav1Cre/+Cpt1afl/fl mice limited hematopoietic progenitor proliferation and myeloid cell expansion after MI. We also observed reduced bone marrow adiposity in humans, pigs and mice after MI. Inhibiting lipolysis in adipocytes using AdipoqCreERT2Atglfl/fl mice or local depletion of bone marrow adipocytes in AdipoqCreERT2iDTR mice also curbed emergency hematopoiesis. Furthermore, systemic and regional sympathectomy prevented bone marrow adipocyte shrinkage after MI. These data establish a critical role for fatty acid metabolism in post-MI emergency hematopoiesis.
- 1 November 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (11) , 2330-2332
TCR-Sequencing Provides a Barcode of Immune Activation and Target Organ Damage in Human Hypertension
- 1 November 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (11) , 2330-2332
TCR-Sequencing Provides a Barcode of Immune Activation and Target Organ Damage in Human Hypertension
- 1 September 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (Suppl_1)
Abstract 033: Innate Lymphoid Cells Mediate Hypertension In T Cell Deficient Hosts
- 1 September 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (Suppl_1)
Abstract 033: Innate Lymphoid Cells Mediate Hypertension In T Cell Deficient Hosts
- Open Access
- 27 September 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 78 (5) , 1648-1661
Chronic 3D Vascular-Immune Interface Established by Coculturing Pressurized Resistance Arteries and Immune Cells
Chronic exposure of the arterial vasculature to high blood pressure recruits immune cells and contributes to the vascular remodeling, dysfunction, and inflammation observed in hypertension. The mechanisms underlying the interaction between vascular and immune cells remain unknown, hampering the development of effective therapies targeting the vascular-immune interface. Overcoming these limitations requires a reliable, physiologically relevant experimental model of vascular-immune interface. By coculturing a 3-dimensional organ culture vascular system with immune cells of interest, we reproduced ex vivo the vascular-immune interface that occurs in hypertension. In the 3-dimensional vascular-immune interface model, CD8 but not CD4 T cells isolated from hypertensive mice increased the contractile properties of resistance arteries in naive mice, indicating that CD8 lymphocytes directly contribute to enhanced peripheral resistance in hypertension. RNA sequencing of CD8 lymphocytes isolated from prehypertensive mice revealed upregulation of gene pathways involved in chemotaxis, response to IFN-γ and other external stimuli, MAPK cascade activation, and positive regulation of intracellular calcium fluxes, as compared with CD4 T cells. Taken together, these results indicate that hypertensive stimuli program CD8 T cells toward a phenotype with promigratory properties that might account for their ability to enhance myogenic tone of resistance arteries when cocultured in the 3-dimensional system. Here, we demonstrate modeling a 3-dimensional organ culture vascular system that recapitulates the in vivo physiological properties of resistance arteries. This platform holds on a substantial translational potential, not only for hypertension but also for other cardiovascular diseases where vascular-immune interfaces are established and relevant for onset and progression of the disease.
- 27 September 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 78 (5) , 1648-1661
Open AccessChronic 3D Vascular-Immune Interface Established by Coculturing Pressurized Resistance Arteries and Immune Cells
Chronic exposure of the arterial vasculature to high blood pressure recruits immune cells and contributes to the vascular remodeling, dysfunction, and inflammation observed in hypertension. The mechanisms underlying the interaction between vascular and immune cells remain unknown, hampering the development of effective therapies targeting the vascular-immune interface. Overcoming these limitations requires a reliable, physiologically relevant experimental model of vascular-immune interface. By coculturing a 3-dimensional organ culture vascular system with immune cells of interest, we reproduced ex vivo the vascular-immune interface that occurs in hypertension. In the 3-dimensional vascular-immune interface model, CD8 but not CD4 T cells isolated from hypertensive mice increased the contractile properties of resistance arteries in naive mice, indicating that CD8 lymphocytes directly contribute to enhanced peripheral resistance in hypertension. RNA sequencing of CD8 lymphocytes isolated from prehypertensive mice revealed upregulation of gene pathways involved in chemotaxis, response to IFN-γ and other external stimuli, MAPK cascade activation, and positive regulation of intracellular calcium fluxes, as compared with CD4 T cells. Taken together, these results indicate that hypertensive stimuli program CD8 T cells toward a phenotype with promigratory properties that might account for their ability to enhance myogenic tone of resistance arteries when cocultured in the 3-dimensional system. Here, we demonstrate modeling a 3-dimensional organ culture vascular system that recapitulates the in vivo physiological properties of resistance arteries. This platform holds on a substantial translational potential, not only for hypertension but also for other cardiovascular diseases where vascular-immune interfaces are established and relevant for onset and progression of the disease.
- Open Access
- 1 December 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (11) , 108494
Celiac Vagus Nerve Stimulation Recapitulates Angiotensin II-Induced Splenic Noradrenergic Activation, Driving Egress of CD8 Effector Cells
- 1 December 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (11) , 108494
Open AccessCeliac Vagus Nerve Stimulation Recapitulates Angiotensin II-Induced Splenic Noradrenergic Activation, Driving Egress of CD8 Effector Cells